SCHEMBL13886067

SCHEMBL13886067

CC(C)n1nc(I)c(=O)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HTR4 Q13639 9/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PDE4A P27815 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ PDE3B Q13370 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MPO P05164 2/20 0.38
▸ SSTR4 P31391 1/20 0.38
▸ NTRK1 P04629 1/20 0.36
▸ P2RX4 Q99571 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19699881 0.90 MPO (0.42) ALDH1A1CYP2C19CYP1A2SMN1; SMN2HTR4
SCHEMBL25357358 0.78 NLRP3 (0.48) ALDH1A1KMT2A
SCHEMBL13885614 0.76 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2POLBP2RX4KDM4E
SCHEMBL13322634 0.75 KMT2A (0.44) ALDH1A1CYP2C19CYP1A2SMN1; SMN2HTR4
SCHEMBL30014534 0.75 KMT2A (0.44) ALDH1A1CYP2C19CYP1A2SMN1; SMN2HTR4
SCHEMBL31495822 0.73 SMN1; SMN2 (0.49) ALDH1A1CYP2C19CYP1A2SMN1; SMN2HTR4
SCHEMBL13174590 0.73 SMN1; SMN2 (0.49) ALDH1A1CYP2C19CYP1A2SMN1; SMN2HTR4
SCHEMBL13886071 0.72 SSTR4 (0.38) ALDH1A1CYP2C19CYP1A2SMN1; SMN2HTR4
SCHEMBL10103719 0.72 MPO (0.42) ALDH1A1CYP2C19CYP1A2SMN1; SMN2HTR4
SCHEMBL13708517 0.72 MPO (0.42) ALDH1A1CYP2C19CYP1A2SMN1; SMN2HTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009053799-A1 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS, S.A. (US) 2009-04-30 — — WO disclosed
Send feedback